Palamon Capital Partners has sold ophthalmology outpatient chain Ober Scharrer Group to Nordic Capital, generating a return of 3.6x invested capital.
Managing partner Craig Ferguson discusses accelerated deployment activity during the pandemic and plans to scale up the PE allocation by 2025
Fund has a target of $600m, which it plans to reach by next year, according to Kommersant
Existing investors including Institut Català de Finances also take part in the financing
Biotech company initially raised €12m in December 2018